Volume 16, Number 3—March 2010
Dispatch
Venezuelan Equine Encephalitis and 2 Human Deaths, Peru
Table 2
Patient code | Age, y/sex | Location | Date of symptom onset | Date of blood collection | Serum titer, PFU/mL | Signs and symptoms |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Death | Bleed* | Fever | Seizure | GI† | Resp‡ | Aches§ | ||||||
Patient 1 FSL2612 | 7/F | Yurimaguas, Loreto | 2006 Jun 19 | 2006 Jun 20 | 1.8 × 104 | + | – | + | + | + | + | + |
FSL2649 | 32/M | Yurimaguas, Loreto | 2006 Aug 7 | 2006 Aug 8 | 3.4 × 104 | – | – | + | – | + | + | + |
IQE1149 | 14/F | Iquitos, Loreto | 2005 Apr 14 | 2005 Apr 15 | 1.0 × 103 | – | – | + | – | – | – | + |
IQE831 | 8/F | Iquitos, Loreto | 2005 Mar 13 | 2005 Mar 14 | 3.0 × 102 | – | – | + | – | – | – | + |
IQE3605 | 6/M | Iquitos, Loreto | 2006 Apr 3 | 2006 Apr 4 | 1.0 × 102 | – | – | + | – | + | – | + |
IQE3741 | 10/F | Iquitos, Loreto | 2006 Apr 21 | 2006 Apr 24 | 5.0 × 102 | – | – | + | – | + | – | + |
IQE5023 | 7/M | Iquitos, Loreto | 2007 Feb 27 | 2007 Feb 28 | 1.3 × 104 | – | – | + | – | + | – | + |
FMD1737 | 18/M | Puerto Maldonado, Madre de Dios | 2007 Dec 17 | 2007 Dec 19 | 5.0 × 102 | – | – | + | – | – | – | + |
FMD1905 | 21/F | Puerto Maldonado, Madre de Dios | 2008 Feb 9 | 2008 Feb 12 | 3.0 × 103 | – | – | + | – | + | – | + |
Patient 2¶ | 25/M | Puerto Maldonado, Madre de Dios | 2005 Feb 24 | 2005 Feb 28 | NM | + | + | + | – | + | – | + |
*Epistaxis, bleeding gums, ecchymosis, purpura, hematochezia, or melena.
†Gastrointestinal (nausea, vomiting, diarrhea, or abdominal pain).
‡Respiratory (cough, dyspnea, or cyanosis).
§Arthralgia, myalgia, bone pain, malaise, or prostration.
¶Virus isolation attempts unsuccessful; ELISA immunoglobulin M results positive for Venezuelan equine encephalitis. NM, not measured.
Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.